A Conversation on Risk in Urology, Including the Pandemic’s Impact on Patient Care

The guest for this episode is Stephen Siegel, MD, a urologist in a multi-specialty group and a medical school classmate of our host. The former classmates discuss the impact of COVID-19 on surgical intervention, delay of diagnosis, and routine screening. They also discuss general risk areas in urology, including transitions of care, telehealth, and risks associated with PSA-level management across a patient’s lifetime. Legal Disclaimer: Information provided in this podcast should not be relied upon for personal, medical, legal, or financial decisions and you should consult an appropriate professional for specific advice that pertains to your situation. Health care providers should exercise their professional judgment in connection with the provision of healthcare services. The information contained in this podcast is not intended to be, nor is it, a substitute for medical diagnosis, treatment, advice, or judgment relative to a patient’s specific condition.   Feedback or episode ideas email the show at [email protected]: Information provided in this podcast should not be relied upon for personal, medical, legal, or financial decisions and you should consult an appropriate professional for specific advice that pertains to your situation. Health care providers should exercise their professional judgment in connection with the provision of healthcare services. The information contained in this podcast is not intended to be, nor is it, a substitute for medical diagnosis, treatment, advice, or judgment relative to a patient’s specific condition.